MEG3 mediated the aggressive behaviors of MEN cells via miR-29c/AKAP12 axis, supporting that MEG3 served as a promising biomarker for the diagnosis and treatment of human MEN. This evidence concerns the gene AKAP12 and multiple endocrine neoplasia.